![]() Weintraub WS, Culler SD, Kosinski A et al (1999) Economics, health-related quality of life, and cost-effectiveness methods for the TACTICS (Treat Angina With Aggrastat and Determine Cost of Therapy with Invasive or Conservative Strategy)-TIMI 18 trial. McCord J, Nowak RM, McCullough PA et al (2001) Ninety-minute exclusion of acute myocardial infarction by use of quantitative point-of-care testing of myoglobin and troponin I. The Danish Study Group on Verapamil in Myocardial Infarction. Launbjerg J, Fruergaard P, Madsen JK et al (1991) Three-year mortality in patients suspected of acute myocardial infarction with and without confirmed diagnosis. Karlson BW, Herlitz J, Wiklund O et al (1991) Early prediction of acute myocardial infarction from clinical history, examination and electrocardiogram in the emergency room. ![]() McCaig LF, Burt CW (2002) National hospital ambulatory medical care survey: emergency department summary. Pollack CV Jr, Sites FD, Shofer FS et al (2006) Application of the TIMI risk score for unstable angina and non-ST elevation acute coronary syndrome to an unselected emergency department chest pain population. Scirica BM, Cannon CP, Antman EM et al (2002) Validation of the thrombolysis in myocardial infarction (TIMI) risk score for unstable angina pectoris and non-ST-elevation myocardial infarction in the TIMI III registry. application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS. Morrow DA, Antman EM, Snapinn SM et al (2002) An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Sabatine MS, McCabe CH, Morrow DA et al (2002) Identification of patients at high risk for death and cardiac ischemic events after hospital discharge. JAMA 284:835–842īudaj A, Yusuf S, Mehta SR et al (2002) Benefit of clopidogrel in patients with acute coronary syndromes without ST-segment elevation in various risk groups. ConclusionĪ modified TIMI risk score may simplify risk stratification of ED patients with undifferentiated chest pain.Īntman EM, Cohen M, Bernink PJ et al (2000) The TIMI risk score for unstable angina/non-ST elevation MI: a method for prognostication and therapeutic decision making. A simplified TIMI risk score was computed and was found to have similar prognostic ability as the 7 variable TIMI risk score. Four of the 7 TIMI risk factors (age ≥65 years, ST segment deviation ≥0.5 mm elevated troponin I, and coronary stenosis ≥50%) were independently associated with adverse events. The mean TIMI risk score was significantly higher in patients with an adverse event compared with those without (2.6 ± 1.3 vs. At 30 days there were 48 (5%) deaths, 84 (9%) myocardial infarctions, and 49 (5%) coronary revascularization procedures. There were 151 (16%) patients diagnosed with ACS. A multivariate analysis was done to evaluate the independent predictive power of the individual components of the TIMI risk score to predict an adverse event at 30 days (all-cause death, myocardial infarction, and coronary revascularization). We investigated the prognostic utility of the TIMI risk score in 947 consecutive patients evaluated in the ED for possible ACS. ![]() The ability of the TIMI risk score to risk stratify patients at initial presentation in the ED with chest pain of unclear etiology is uncertain. To assess the prognostic utility of the Thrombolysis in Myocardial Infarction (TIMI) risk score in patients in the emergency department (ED) evaluated for possible acute coronary syndrome (ACS). ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |